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Single-operator cholangioscopy is useful for 
visual assessment of bile duct pathology
Finnur Mellemgaard, Rune B. Strandby, Julie Blockmann, Steen C. Kofoed, Lars B. Svendsen & Michael P. Achiam 
Endoscopic retrograde cholangiopancreatography 
(ERCP) is commonly used for initial evaluation of bil-
iary tree strictures including tumours, inflammation 
and biliary stones [1]. The drawbacks of ERCP, how-
ever, are that inspection of the biliary ducts is per-
formed indirectly from a cholangiogram displayed by 
X-rays. Also, tissue biopsies from lesions within the bil-
iary ducts are obtained by brush cytology, and for this 
method a sensitivity below 60% has been reported for 
the diagnosis of malignant biliary lesions [2, 3]. 
Peroral cholangioscopy has been performed since 
1975. Contrary to ERCP, this allows the operator to  
assess the pancreatic and biliary ducts visually [4]. 
However, the procedure was not widely used because 
the first cholangioscopes on the market were expen-
sive, fragile and required two operators [5]. In 2007, 
Boston Scientific launched a single-operator cholangi-
oscopy (SOC) device named SpyGlass Direct Visualiza-
tion System, which also allowed direct visualisation of 
the biliary ducts, and which only required one operator 
[6]. The platform consists of a reusable fibre optic 
probe for imaging (SpyGlass Direct Visualization 
Probe), which can be inserted through a disposable ac-
cess and delivery catheter (SpyScope) attached to the 
duodenoscope. Through the catheter, irrigation of the 
biliary duct is possible and small tissue biopsies can be 
obtained through a separate working channel (SpyBite 
biopsy forceps). 
Similarly to the ERCP, the main indications for SOC 
are evaluation of undetermined biliary duct strictures 
and removal of firmly lodged stones [7]. Studies have 
reported that Spyglass is feasible with procedure-re-
lated success rates of up to 97%, and SOC is fairly time-
consuming in comparison with ERCP [8, 9]. 
The aim of this study was to evaluate the overall 
feasibility of SOC during a seven-year period at a ter-
tiary Danish referral centre by determining the visual 
and histological success rates. Moreover, we examined 
whether or not visual SOC findings offered additional 
diagnostic information compared with tissue biopsies 
obtained by ERCP.  
METHODS 
All patients who underwent SOC at a single Danish ter-
tiary referral centre between 2008 and 2015 were iden-
tified by searching for specific procedure codes in the 
hospital’s local database (Endobase). Initially, patient 
records were evaluated individually by two reviewers 
(FM, JB) and data were retrieved in two separate 
sheets. Then, data were reassessed in a joint session  
by two of the authors (RBS, FM) to rule out any dis-
crep ancies, and a final decision was made. The study 
was approved by The Danish Data Protection Agency  
(RH-2015-229) and the Danish Health Authority  
(3-3013-1299/1). 
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SUMMARY
INTRODUCTION: Single-operator cholangioscopy (SOC) is 
increasingly used for evaluation of the biliary tree following 
endoscopic retrograde cholangiopancreaticography (ERCP). 
This study aimed to determine the visual and histological 
success rates of SOC at a single Danish tertiary referral 
centre. 
METHODS: All patients undergoing SOC between 2008 and 
2015 were retrospectively included from a prospectively 
maintained database. Patient characteristics and proced-
ure-related variables were obtained from medical records.  
A visual and a histological success rate were determined 
according to predefined criteria. 
RESULTS: In total, 54 patients underwent SOC, most often 
due to suspicion of malignancy (n = 53; 98%). In one case, 
access to the common bile duct failed, and in six cases 
malignant disease was missed. Thus, the cholangioscopies 
were successful in 47 of 54 procedures corresponding to a 
visual success rate of 87%.  
Nine patients (17%) had a mean of 1.3 ± 1.0 SOC-guided 
biopsies taken. The extracted tissue was inadequate for 
histological evaluation in seven of nine cases, corres pond-
ing to a histological success rate of 22% (two out of nine 
tissue samples were eligible for histological diagnosis). 
CONCLUSIONS: Considering the reasonable visual success 
rate, SOC seems to be a useful extension of ERCP during 
diagnostic work-up for detection of malignant disease in the 
biliary tree. However, one biopsy per patient is insufficient 
for histological verification of common bile duct malignancy. 
TRIAL REGISTRATION: The Danish Health Authority (3-3013-
1299/1) and The Danish Data Protection Agency (RH-2015-
229).
FUNDING: none.
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One experienced endoscopist performed all proced-
ures. Firstly, an oesophagogastro-duodenoscopy was 
carried out under propofol sedation. Then, following 
cannulation of the major duodenal papilla, a catheter 
was placed in the common bile duct and a cholangiog-
raphy was carried out by injection of a contrast agent 
(Omnipaque, GE Healthcare, Little Chalfont, UK). If in-
dicated, biopsies or a brush cytology was obtained. 
SOC was performed with a reusable fibre optic probe 
(SpyGlass, Boston Scientific, Massachusetts, USA) cap-
able of tip deflection at least 30° in four directions 
(Figure 1). The probe was introduced through a dis-
posable access and delivery catheter (SpyScope, Boston 
Scientific, Massachusetts, USA) attached to the duo-
den oscope. The biliary duct was then inspected visually 
and, if required, the biliary duct was irrigated with sa-
line to optimise visibility. Tissue biopsies were ob-
tained, if indicated by the endoscopist, using a 3-Fr  
forceps with a 4.1 mm jaw opening (SpyBite, Boston 
Scientific, Massachusetts, USA). For stone removal,  
an ERCP-guided basket or balloon was used.   
The main outcome was the success rate of the SOC 
procedure defined as: 1) Achieved access to the com-
mon bile duct; 2) Adequate visualisation of target le-
sions; 3) No missed malignant lesions; 4) SOC-guided 
biopsies (if obtained) deemed adequate for histological 
evaluation by the pathologist [8]. The visual assess-
ment of SOC was considered successful if requirements 
one to three were met. Likewise, histological assess-
ment of SOC was considered successful if requirement 
four was fulfilled. In addition, an overall success rate 
including both visual and histological results was deter-
mined. Findings with SOC were categorised into three 
groups. “Malignant disease” was defined as either an 
obvious or a strong suspicion of malignancy, including 
undetermined biliary duct stenosis, papillomatosis, 
cholangiocarcinoma or intraductal papillary mucinous 
neoplasm. “Non-malignant suspicion” was defined as 
identification of biliary stones, stenosis without sus-
picion of malignancy or other benign abnormalities. 
Finally, “non-pathology” was defined as disease-free 
bile ducts as assessed by the endoscopist.   
By decision of the endoscopist, some patients had 
ERCP-guided brush cytology and/or papillary biopsies 
from the major duodenal papilla obtained in addition 
to SOC. For these patients, histological findings from 
ERCP-guided biopsies were compared with SOC re-
sults.  
Statistical calculations were carried out by SPSS 
(IBM SPSS Statistics for Windows, version 22.0, 
Armonk, NY, USA). For distribution of dependent vari-
ables, descriptive statistics was used.    
RESULTS 
Single-operator cholangioscopy 
A total of 54 patients underwent SOC. Baseline charac-
teristics are shown in Table 1.  
The main indication for SOC was suspicion of  
malignancy (n = 53; 98%), but in one patient visual 
examination of the common bile duct following lapar-
oscopic cholecystectomy was necessary. The visual SOC 
findings resulted in suspicion of: malignant disease in 
13 (24%) patients, non-malignant disease in 25 (46%) 
patients and non-pathology in 15 (28%) patients 
(Figure 2). In one case, visibility was inadequate due 
to angulation of the common bile duct, and malignant 
disease was missed in six cases. Malignancy was, how-
ever, confirmed by diagnostic laparoscopy (n = 3) and 
by brush cytology (n = 3). Thus, a successful visual 
SOC evaluation was achieved in 47 out of 54 cases,  
corresponding to a visual success rate of 87%.
TAbLE 2
SpyBite biopsy summary. Values are n (%).
Biopsies Patients Successful procedures 
 
1 6 (11) 0
2 2 (4) 1
4 1 (2) 1
Total 9 (17) 2 (22)
TAbLE 1
Baseline characteristics. 
Male sex, n (%) 21 (39)
Age, yrs, mean ± SD 60 ± 14.1
ASA score, mean ± SD 2 ± 0.5
BMI, kg/m2, mean ± SD 25 ± 5.5
Tobacco: active & former use, n (%) 28 (52)
Alcohol: active & former abuse, n (%) 10 (19)
ASA = American Society of Anaesthesiologists; SD = standard deviation.
FIGURE 1
A. Cholangiography by endoscopic retrograde cholangiopancreaticography. b. The biliary con-
fluence visualised by single-operator cholangioscopy. C. Bile stone in the common hepatic bile 
duct visualised by single-operator cholangioscopy. 
A B C
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A small number of patients (n = 9; 16.7%) had 
SOC-guided biopsies obtained, and a mean of 1.3 
(standard deviation: ± 1.0) biopsies were examined 
per patient (Table 2). However, the sampled tissue was 
inadequate for histological evaluation in seven out of 
nine cases, corresponding to a success rate of 22%. 
Overall, 63 procedures were performed: 54 visual 
assessments with SOC and nine histological evalu-
ations. In total, 49 of 63 procedures were successful 
yielding an overall success rate of 78%. 
Endoscopic retrograde cholangiopancreaticography 
In addition to SOC, 32 patients had ERCP-guided bi-
opsies obtained as brush cytology from the common 
bile duct and/or tissue biopsies from the major duo-
denal papilla. The histological results comprised eight 
(25%) malignant cases, 22 (69%) non-malignant cases, 
and two cases (6%) that were inadequate for evalu-
ation (Figure 3). In nine of the 22 cases where ERCP-
guided biopsies indicated non-malignant disease,  
SOC gave rise to visible suspicion of malignant disease.  
Malignancy was eventually confirmed in five out of 
nine cases by diagnostic laparoscopy (n = 4) and by 
CT/MRI (n = 1). On the other hand, malignant disease 
was identified in three patients by ERCP-guided bi-
opsies, where malignant disease was missed by SOC 
(Figure 3).    
Final treatment and complications     
A total of 16 (30%) patients were treated for malig-
nancy, including intended curative surgery (n = 10; 
2%), palliative chemotherapy or stent placement (n = 
3; 6%), and no treatment by patient request (n = 3; 
6%). Benign diseases (n = 13; 24%) were treated with 
stone extraction via ERCP (n = 4; 7%), stent placement 
(n = 5; 9%), cholecystectomy (n = 3; 6%) or balloon 
dilatation with ERCP (n = 1; 2%). The remaining pa-
tients (n = 25; 46%) received no treatment.  
Following the SOC procedure, 11 (20%) patients 
had complications: haemorrhage (n = 1; 2%), upper 
abdominal pain (n = 7; 13%), fever (n = 2; 4%) and 
vomiting and nausea (n = 3; 6%). Two patients had 
more than one type of complication. Haemostasis was 
achieved with an ERCP-guided balloon and abdominal 
pain, fever, vomiting and nausea were treated success-
fully with analgesics or antibiotics. No patients devel-
oped post-procedural pancreatitis. 
DISCUSSION
This study found a visual success rate of 87% and a his-
tological success rate of 22%, using SOC by a single ex-
perienced endoscopist, corresponding to an overall suc-
cess rate of 78%. 
Overall, the visual success rate found in this case  
series is in line with that of other studies, including a 
larger study with 297 patients, in which a visual suc-
cess rate of 93% was reported [9]. Malignant disease 
was, however, missed in six cases (11.1%) during vis-
ible assessment with SOC in this study. Fortunately, 
these malignant tumours were detected with other  
diagnostic procedures, including ERCP-guided brush 
cytology (n = 3) and diagnostic laparoscopy (n = 3), 
indicating that visual assessment with SOC should not 
stand alone in clinical decision making. In contrast,  
FIGURE 2
Visual SOC results:
54
Malignant suspicion:
13 (24)
Concluded malignant by DL:
6 (11)
Concluded malignant by  
ERCP-biopsy:
4 (7)
Concluded malignant by 
brush cytology:
3 (6)
Concluded malignant by DL:
3 (6)
3 (6) 34 (63)10 (19) 6 (11)
Non-malignant suspicion/non-pathology:
40 (74)
Treatment for malignant disease:
16 (30)
Treatment for non-malignant disease:
38 (70)
Failed: angulation of the duct:
1 (2)
Visual single-operator 
cholangioscopy results. 
Values are number of 
patients (%).
DL = diagnostic laparoscopy; ERCP = endoscopic retrograde cholangiopancreatography; SOC = single-operator cholangioscopy.
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malignant disease was identified in five patients with 
SOC in whom ERCP-guided biopsies were deemed non-
malignant. Therefore, ERCP and visible SOC seem to 
support each other during endoscopic evaluation of the 
duodenum and common bile duct. Nevertheless, both 
SOC and ERCP lack sensitivity for detection of extra 
ductal disease, exemplified by the three patients in 
whom malignancy was missed endoscopically but con-
firmed during diagnostic laparoscopy. 
In this study, nine patients had SOC-guided biopsies 
obtained, but only two tissue samples were adequate 
for histological evaluation, yielding a success rate of 
22%. Of note, only one biopsy was obtained per patient 
on average and, consequently, our results should be in-
terpreted with caution. At our institution, ERCP-guided 
brush cytology is the preferred modality for obtaining 
cells for histological evaluation, which probably ex-
plains the low number of tissue samples obtained with 
SOC. When tissue is collected, the SpyBite forceps have 
to be clutched completely together in order to with-
draw the wire, including the very small amount of ex-
tracted tissue. In addition, repeating this procedure can 
be time-consuming. A study with 36 patients included 
an average of four SOC-guided biopsies per patient and 
reported a mean sampling time of 12 minutes, which 
accounts for approximately one fifth of the total pro-
ced ure length [8]. For that reason, brush cytology may 
seem more feasible. Nevertheless, the histological suc-
cess rate for SOC in other studies ranges between 70-
100% [2, 10], with increasing success rates (88% or 
above) when four or more biopsies are evaluated per 
patient [9]. Likewise, one study with 165 patients re-
ported that obtaining at least four, versus less than four 
biopsies, increased the adequacy of the specimens 
(90% versus 64%) [11]. A new generation of SOC, 
SpyGlass DS Direct Visualization System released in 
2015, is also believed to improve the diagnostic accur-
acy. Recent reports indicate that the diagnostic yield of 
malignant disease based on forceps biopsies has im-
proved compared with the older generation of forceps 
used in this study [12, 13]. In addition, the SpyGlass 
DS is easier to set up and comes with an improved digi-
tal image with a 60% wider field of view [14]. Also,  
the device has the capability of suctioning to ease over-
view.  
In our series, procedure-related complications oc-
curred in 11 patients (20%), and all were treated suc-
cessfully. Other studies have reported a prevalence of 
complications ranging 3-10% [8], [12, 15]. The higher 
complication rate found in this study is probably re-
lated to the fact that 13% of the patients had com-
plaints of abdominal pain following SOC. Since pain is 
a subjective measure and is to some degree expected 
following a procedure like ERCP and SOC, definitions 
of when pain should be considered a complication may 
differ among studies. Of note, in contrast to others, 
none of our patients developed pancreatitis after the 
procedure, and SOC generally seems to be a safe pro-
ced ure with a complication risk equalling that associ-
ated with ERCP, i.e. 4-15% [16]. One study even found 
FIGURE 3
Results from patients 
undergoing single- 
operator cholangios-
copy with additional 
endoscopic retrograde 
cholangiopancreatog-
raphy-guided biopsies 
obtained by brush  
cytology and/or papil-
lary biopsies from the 
major duodenal papilla.  
Values are number  
of patients (%).
Results from patients undergoing SOC 
with additional ERCP-guided biopsies:
32
Malignant suspicion:
8 (25)
Concluded malignant by DL:
4 (13)
Concluded malignant by  
MRI, CT, or SOC:
1 (3)
Concluded non-malignant:
4 (13)
Malignant suspicion, 
SOC:
5 (16)
Non-malignant suspicion/
non-pathology, SOC:
13 (41)
Non-malignant suspicion/
non-pathology, SOC:
3 (9)
Malignant suspicion, SOC:
9 (28)
Non-malignant suspicion:
22 (69)
Treatment for malignant disease:
13 (41)
Treatment for non-malignant disease:
17 (53)
Failed:  
inadequate for histologic evaluation
2 (6)
DL = diagnostic laparoscopy; ERCP = endoscopic retrograde cholangiopancreatography; SOC = single-operator cholangioscopy.
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that haemorrhage occurred more often during ERCP 
than SOC. The same study found no difference in the 
prevalence of pancreatitis, nor in overall complication 
risk [16]. In contrast, one study demonstrated that SOC 
may be associated with higher rates of cholangitis than 
ERCP [17]. This may be related to lengthier procedure 
times resulting in an increased amount of intraluminal 
air being inflated into the biliary duct besides saline 
used for irrigation causing further distention. Taken to-
gether, serious complications following SOC seem to be 
rare. Nevertheless, we think that SOC should be per-
formed by trained endoscopists in specialised centres 
accustomed to handling SOC-related complications.  
In line with this, we are aware of eight centres in Den-
mark that perform SOC at this point, all possessing ad-
vanced endoscopic competence.   
The strengths of this study include, firstly, complete 
registration of data. Since our institution started using 
SOC in 2008, all procedures have been registered pro-
spectively. Therefore, we consider that the risk of selec-
tion bias is small. Secondly, one experienced endos-
copist performed all procedures thereby reducing 
variability in operator-dependent variables like visual 
assessment. The main limitations of this study include 
the low number of included patients and, especially, 
the few SOC-guided biopsies available for histological 
assessment. This may reduce external validity. Also,  
we acknowledge that follow-up was limited to the time  
period around the SOC. Hence, patients considered 
with non-malignant disease could potentially have 
been re-examined months later and diagnosed with a 
cancer at that time. Therefore, one SOC/ERCP session 
may not be sufficient to rule out malignancy.    
CONCLUSIONS
A reasonable visual success rate can be achieved with 
SOC and the modality seems to be a useful extension  
of ERCP as part of the diagnostic work-up for detection 
of malignant disease in the common bile duct. For reli-
able histological results, a single biopsy of the sus-
pected lesion is inadequate, but our low sample size 
does not allow us to conclude on the value of SOC-
guided bi opsies. 
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